U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a new federal initiative to build a comprehensive autism data platform using Medicare and Medicaid records. Designed to study the causes of autism spectrum disorder (ASD), the platform will integrate claims data, electronic health records, and data from wearable health devices, according to the Department of Health and Human Services (HHS).
The National Institutes of Health (NIH) and the Centers for Medicare and Medicaid Services (CMS) will collaborate on the effort, which is part of a broader $50 million research initiative to investigate potential environmental and medical causes of autism. Kennedy stated the project aims to provide "honest answers families have waited far too long to hear," despite his controversial history promoting a debunked link between vaccines and autism.
HHS said the platform will help researchers analyze autism diagnoses, treatment outcomes, healthcare access disparities, and the financial impact on families. However, experts like Dr. Helen Tager-Flusberg of Boston University argue the focus does not directly address autism’s root causes. She also noted that an existing NIH autism database recently went offline without explanation, raising concerns about transparency.
The project has sparked privacy questions, as HHS has not confirmed whether the database will be anonymous or voluntary. Autism researcher Eric Rubenstein noted that Medicaid and Medicare data offer insights into health disparities but lack environmental exposure data, which Kennedy claims he will explore.
Autism rates have surged in recent years, with the CDC reporting 1 in 31 U.S. 8-year-olds diagnosed in 2022. While Kennedy aims to identify autism’s causes by September, scientists emphasize that autism likely stems from a complex mix of genetic and environmental factors. Critics warn against oversimplifying this ongoing scientific challenge.


Trump Opens Tax-Exempt Dyed Diesel Access as Fuel Prices Surge
Trump Signs Order to Cut Routine Childhood Vaccines
Florida Seeks Tougher Meta Rules to Protect Young Users
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
France to Release 10 Million Barrels of Diesel to Ease Fuel Prices
Israel Tightens Pilot Security After Flydubai Incident
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial
Novo Nordisk Strikes €1.17 Billion Nanexa Drug Delivery Deal
New York Declares Measles Disaster Emergency as Cases Surge
Fairshake Backs 32 Pro-Crypto House Candidates
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
US DOT Ends Airline Privacy Review Without Enforcement
SEC Investor Reform Validates Barry Silbert’s Tokenization Vision
U.S. Issues Cuba Health Alert as Illnesses Rise
FDA Weighs Safety Standards for Psychedelic Therapies
US Suspends Microsoft, Adobe From Green Card Program 



